Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Holdings
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
CC transcript
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/10/2023
144
Form 144 - Report of proposed sale of securities:
08/10/2023
144
Form 144 - Report of proposed sale of securities:
08/10/2023
144
Form 144 - Report of proposed sale of securities:
08/09/2023
10-Q
Quarterly Report for the period ended July 1, 2023
08/09/2023
8-K
Quarterly results
07/07/2023
SC 13G/A
BlackRock Inc. reports a 10.2% stake in CHARLES RIVER LABORATORIES INTERNATIONAL INC
05/25/2023
SD
Form SD - Specialized disclosure report:
05/15/2023
144
Form 144 - Report of proposed sale of securities:
05/12/2023
144
Form 144 - Report of proposed sale of securities:
05/11/2023
144
Form 144 - Report of proposed sale of securities:
05/11/2023
10-Q
Quarterly Report for the period ended April 1, 2023
05/11/2023
8-K
Quarterly results
Docs:
"
Charles River Laboratories Announces First-Quarter 2023 Results – First-Quarter Revenue of $1.03 Billion – – First-Quarter GAAP Earnings per Share of $2.01 and Non-GAAP Earnings per Share of $2.78 – – Updates 2023 Guidance –
"
05/01/2023
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/30/2023
ARS
Form ARS - Annual Report to Security Holders:
03/30/2023
DEF 14A
Form DEF 14A - Other definitive proxy statements:
02/22/2023
10-K
Annual Report for the period ended December 31, 2022
02/22/2023
8-K
Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data
Docs:
"
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance – Fourth-Quarter Revenue of $1.10 Billion and Full-Year Revenue of $3.98 Billion – – Fourth-Quarter GAAP Earnings per Share of $3.65 and Non-GAAP Earnings per Share of $2.98 – – Full-Year GAAP Earnings per Share of $9.48 and Non-GAAP Earnings per Share of $11.12 – – Provides 2023 Guidance –
"
01/31/2023
SC 13G/A
FMR LLC reports a 1.1% stake in CHARLES RIVER LABS INTL INC
12/06/2022
8-K
Quarterly results
11/30/2022
8-K
Quarterly results
11/02/2022
10-Q
Quarterly Report for the period ended September 24, 2022
11/02/2022
8-K
Quarterly results
08/03/2022
10-Q
Quarterly Report for the period ended June 25, 2022
08/03/2022
8-K
Quarterly results
Docs:
"
Charles River Laboratories Announces Second-Quarter 2022 Results – Second-Quarter Revenue of $973.1 Million – – Second-Quarter GAAP Earnings per Share of $2.13 and Non-GAAP Earnings per Share of $2.77 – – Reduces 2022 Guidance –
"
06/08/2022
8-K
Quarterly results
05/26/2022
SD
Form SD - Specialized disclosure report:
05/12/2022
8-K
Quarterly results
05/04/2022
10-Q
Quarterly Report for the period ended March 26, 2022
05/04/2022
8-K
Quarterly results
04/25/2022
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/30/2022
DEF 14A
Form DEF 14A - Other definitive proxy statements:
03/28/2022
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/16/2022
10-K
Annual Report for the period ended December 25, 2021
02/16/2022
8-K
Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data
Docs:
"
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2021 Results – Fourth-Quarter Revenue of $905.1 Million and Full-Year Revenue of $3.54 Billion – – Fourth-Quarter GAAP Earnings per Share of $2.67 and Non-GAAP Earnings per Share of $2.49 – – Full-Year GAAP Earnings per Share of $7.60 and Non-GAAP Earnings per Share of $10.32 – – Reaffirms 2022 Guidance –
"
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy